Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000017
Filing Date
2025-03-07
Accepted
2025-03-06 21:37:49
Documents
26
Period of Report
2025-03-07

Document Format Files

Seq Description Document Type Size
1 6-K a2025-03x07inclusioninspxa.htm 6-K 27444
2 EX-99.1 exhibit991.htm EX-99.1 7686
3 EX-99.2 exhibit992.htm EX-99.2 10194
4 EX-99.3 exhibit993.htm EX-99.3 4276
5 EX-99.4 exhibit994.htm EX-99.4 7128
6 EX-99.5 exhibit995.htm EX-99.5 5058
7 exhibit991001.jpg GRAPHIC 277341
8 exhibit991002.jpg GRAPHIC 183344
9 exhibit992001.jpg GRAPHIC 71732
10 exhibit992002.jpg GRAPHIC 143343
11 exhibit992003.jpg GRAPHIC 121593
12 exhibit992004.jpg GRAPHIC 67697
13 exhibit992005.jpg GRAPHIC 90755
14 exhibit992006.jpg GRAPHIC 112491
15 exhibit992007.jpg GRAPHIC 47065
16 exhibit993001.jpg GRAPHIC 148261
17 exhibit993002.jpg GRAPHIC 109959
18 exhibit994001.jpg GRAPHIC 73188
19 exhibit994002.jpg GRAPHIC 59598
20 exhibit994003.jpg GRAPHIC 60662
21 exhibit994004.jpg GRAPHIC 148905
22 exhibit994005.jpg GRAPHIC 37524
23 exhibit994006.jpg GRAPHIC 95222
24 exhibit995001.jpg GRAPHIC 146910
25 exhibit995002.jpg GRAPHIC 123337
26 exhibit995003.jpg GRAPHIC 57621
  Complete submission text file 0001345099-25-000017.txt   3061520
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 25717375
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)